Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
HLGN.WS
HLGN.WS was delisted on the 7th of November, 2023.
3 hedge funds and large institutions have $25.2K invested in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
82% less capital invested
Capital invested by funds: $137K → $25.2K (-$111K)
82% less funds holding
Funds holding: 17 → 3 (-14)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Corbin Capital Partners
New York
|
-$19.3K |
| 2 |
D.E. Shaw & Co
New York
|
-$8.95K |
| 3 |
Jane Street
New York
|
-$4.54K |
| 4 |
FPA
First Pacific Advisors
El Segundo,
California
|
-$4.38K |
| 5 |
AC
Antara Capital
New York
|
-$3.79K |
HLGN.WS Hedge Fund Activity: Q4 2023 in Review
3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) for Q4 2023, worth a combined $25.2K — down 82% from $137K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of HLGN.WS and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Corbin Capital Partners, exiting entirely with an estimated $19.3K sold.
- 3 institutional investors held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) as of Q4 2023, down from 17 in Q3 2023.
- Funds reported $25.2K of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 stock for Q4 2023, down 82% quarter-over-quarter.
- 0 funds opened new Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 positions in Q4 2023 and 14 closed out, a net change of -14 holders.
- The largest Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 seller in Q4 2023 was Corbin Capital Partners, an estimated $19.3K sold.
Based on aggregated 13F filings for Q4 2023.